| Literature DB >> 35445050 |
Mohamed Elsherif1, Rosalia Moreddu2, Fahad Alam1, Ahmed E Salih1, Israr Ahmed1, Haider Butt1.
Abstract
Diabetes mellitus is a chronic disease requiring a careful management to prevent its collateral complications, such as cardiovascular and Alzheimer's diseases, retinopathy, nephropathy, foot and hearing impairment, and neuropathy. Self-monitoring of blood glucose at point-of-care settings is an established practice for diabetic patients. However, current technologies for glucose monitoring are invasive, costly, and only provide single snapshots for a widely varying parameter. On the other hand, tears are a source of physiological information that mirror the health state of an individual by expressing different concentrations of metabolites, enzymes, vitamins, salts, and proteins. Therefore, the eyes may be exploited as a sensing site with substantial diagnostic potential. Contact lens sensors represent a viable route for targeting minimally-invasive monitoring of disease onset and progression. Particularly, glucose concentration in tears may be used as a surrogate to estimate blood glucose levels. Extensive research efforts recently have been devoted to develop smart contact lenses for continual glucose detection. The latest advances in the field are reviewed herein. Sensing technologies are described, compared, and the associated challenges are critically discussed.Entities:
Keywords: contact lenses; enzymes; fluorescence; glucose sensors; light diffraction; phenylboronic acid
Year: 2022 PMID: 35445050 PMCID: PMC9013844 DOI: 10.3389/fmed.2022.858784
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
Figure 1Schematics showing the proposed methods for vision correction: (A) Leonardo da Vinci concept: a man looking through a bowel filled of water, and (B) René Descartes concept: a man looking through a tube filled with fluid. (C) Categories of contact lenses based on the constituents materials.
Comparison among the different categories of contact lenses and some selected commercial contact lenses (9).
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|
| Soft hydrogel CLs | i. Increased initial comfort | i. Worn for short period compared to hard lenses | HEMA | 38 | Bausch & Lomb | Polymacon |
| PVA | 69 | Alcon | Dailies AquaComfort plus | |||
| HEMA, DAA, MAA | 45 | CIBA Vision | Soft Mate II | |||
| HEMA, MAA | 58 | Johnson & Johnson | 1-d Acuvue moist | |||
| HEMA, MAA | 55 | Coopervision | Frequency 55 | |||
| Silicon soft CLs | i. High oxygen permeability | i. Not suitable for people with silicon intolerance | Alkyl methacrylates, siloxane, NVP | 56 | Sauflon | Clarity 1 d |
| SIMA, SIA, DMA, pyrolidone derivative | 40 | Menicon | Premi | |||
| NVP, VMA, IBM, TAIC, FM0411M, HOB | 48 | Coopervision | Biofinity | |||
| NVP, TPVC, NCVE, PBVC | 36 | Bausch & Lomb | Pure Vision | |||
| Hard CLs | i. Offer sharp vision | i. Require a period for adaptation | Fluorosilicone acrylate | N/A | InnoVision | Accucon |
| Silicone Acrylate | N/A | Bausch & Lomb | Boston II | |||
| Fluoro-Silicate Acrylic | N/A | G.T Laboratories | Fluorex 300 | |||
| Fluorosilicate Acryle | N/A | Contamac | Hybrid FS | |||
| Fluoro-Siloxayanyl Styrene | N/A | Menicon | Menicon Z | |||
| Hybrid CLs | i. Increased oxygen permeability | i. More careful evaluation of lens-to-anterior segment required | Silicone hydrogel/RGP | 50% for the silicone hydrogel skirt | EyeBrid Silicone | Eyebrid |
| Silicon hydrogel Filcon V3/roflufocon D | 50% for the silicon hydrogel skirt | SwissLens | AirFlex |
Comparison between tear and blood biomarkers, and their applications.
|
|
|
|
|
|
|---|---|---|---|---|
| Glucose | 0.01–0.05 | 3.3–6.5 | Diabetes | ( |
| Lactate | 2.0–5.0 | 0.36–0.75 | Cancer, sepsis, ischemia, and liver disease. | ( |
| Urea | 3.0–6.0 | 3.3–6.5 | Renal function | ( |
| Dopamine | 0.37 | 475 ×10−9 | Glaucoma | ( |
| Total protein | 7 g/L | 7 g/L | Dry eye syndrome | ( |
| Pyruvate | 0.05–0.35 | 0.1–0.2 | Genetic disorders of mitochrondrial energy metabolism | ( |
| Ascorbate | 0.22–1.31 | 0.04–0.06 | Diabetes | ( |
| Na+ | 120–165 | 130–145 | Hypo/hypernatremia | ( |
| Cortisol | 1–40 ng/ml | 100–200 mcg/ml | Stress levels and brain injuries | ( |
| Cl− | 118–135 | 95–125 | Hyper/hypochloremia | ( |
| Ca2+ | 0.4–1.1 | 2.0–2.6 | Hyper/hypocalcemia | ( |
| HCO | 20–26 | 24–30 | Respiratory quotient indicator | ( |
| Mg2+ | 0.5–0.9 | 0.7–1.1 | Hyper/hypomagnesemia | ( |
| K+ | 20–42 | 3.5–5.0 | Hyper/hypokalemia and an indicator for ocular disease | ( |
Figure 2Florescence-based smart contact lens for tear glucose sensing. (A) Photographs of the rabbit wearing the smart contact lens under ambient light illumination. (B) The rabbit eye wearing contact lens under illumination by UV LED light. (C) The worn lens in artificial tears containing glucose of 1 mM concentration. (D) The worn lens in artificial tears containing glucose of 5 mM concentration. (E) Blood glucose levels measured by a commercial glucose meter over time and their corresponding tear glucose levels measured by analyzing the fluorescent signals emitted from the contact lens worn on the rabbit eye. (F) The ratio of the blue and red channel (B/R) for the images taken for the contact lens worn in the rabbit eye and immersed in artificial tears with different glucose concentrations (67).
Figure 3A stretchable transparent smart contact lens system. (A) Schematic diagram of the soft contact lens; the lens is composed of a hybrid substrate, functional devise (rectifier, LED, and glucose sensor), and a transparent stretchable conductor (for antenna and interconnects). (B) A diagram of the circuit used in the smart contact lens system. (C) Operation of the smart contact lens; the electric power is wirelessly transmitted to the lens through the antenna, which in turn activates the LED pixel and the glucose sensor. The pixel turns off once the detected glucose level exceeds the normal limit (80).
Figure 4Smart contact lenses for wireless glucose detection. (A–E) Electrochemical sensor integrated with a contact lens: (A) schematic illustration of the transparent glucose sensor integrated in the contact lens, (B) schematic illustration of the reading circuit in the wireless sensing mode, (C) wireless glucose measurements in the glucose range of 1–10 mM, (D) photographs of the smart contact lens placed on rabbit eyes, and (E) wireless glucose detection by the smart contact lens in vitro and in vivo (79).
Figure 5Smart contact lenses for glucose monitoring developed based on light diffractive sensors. (A–C) A light diffraction-based glucose sensor integrated with a soft contact lens: (A) a soft commercial contact lens placed on an eye ball (i), and the commercial contact lens integrated with a 1D grating glucose sensor (ii), (B) schematic illustration of the readout methodology for the contact lens integrated with the 1D grating glucose sensor, and (C) continuous glucose detection measurements shows the reflected optical power from the contact lens vs. the glucose concentration (105). (D–F) Light diffuser-based glucose sensor: (D) optical microscope image for the master holographic light diffuser, (E) the surface of the glucose sensor imprinted with the light diffuser microstructures, and (F) photographs of the smart contact lens integrated with the light diffuser-glucose sensor and placed on an eye ball to be investigated by a smartphone as a reader (106). (G,H) Bifocal contact lenses for glucose detection: (G) schematic illustration of the bifocal contact lens in glucose-free buffer, and (H) schematic of the bifocal contact lens in glucose-complexation conditions (107).